Skip to main content
Premium Trial:

Request an Annual Quote

Ingenuity Extends License with GlaxoSmithKline

NEW YORK (GenomeWeb News) – Ingenuity Systems announced today that it has extended and expanded its licensing agreement with GlaxoSmithKline providing the drug giant with access to Ingenuity Pathways Analysis software.
 
The new pact enables GSK to provide enterprise-wide IPA access to researchers assessing signaling and metabolic pathways, molecular networks, and biological processes that are most significant to disease targets. GSK also will use Ingenuity’s content and proprietary algorithms, the Redwood City, Calif.-based bioinformatics firm said in a statement.
 
Financial terms of the agreement were not disclosed.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.